The Oncology Institute(US:TOI) Globenewswire·2025-05-07 21:03Core Insights - Topicus.com Inc. reported a total revenue of €355.6 million for Q1 2025, marking a 16% increase from €306.6 million in Q1 2024, driven primarily by acquisitions and organic growth of 4% [4][8] - Net income for the same period rose to €38.8 million, up from €28.3 million in Q1 2024, translating to earnings of €0.30 per diluted share compared to €0.22 [5][8] - Cash flows from operations increased by 19% to €271.4 million, while free cash flow available to shareholders (FCFA2S) grew by 21% to €161.7 million [5][8] Financial Performance - Total revenue for Q1 2025 was €355.6 million, an increase of €49.0 million compared to the same period in 2024 [4][8] - Net income increased by €10.5 million to €38.8 million, with earnings per share rising to €0.30 from €0.22 [5][8] - Cash flows from operations (CFO) rose by €43.9 million to €271.4 million, representing a 19% increase [5][8] Acquisitions and Investments - The company completed acquisitions for a total cash consideration of €39.4 million, with deferred payments estimated at €20.9 million, leading to a total consideration of €60.3 million [8] - On January 31, 2025, Topicus acquired 8,300,029 shares in Asseco Poland S.A. for €168.0 million, representing approximately 9.99% of Asseco's issued shares [8] Comprehensive Income - Total comprehensive income for Q1 2025 was €183.9 million, significantly higher than €30.2 million in Q1 2024, driven by a gain of €145.5 million from equity investments [20][21]